Company Profile
Shenyang Botai Biopharmaceutical Co., Ltd. was established in February 2018 and is located at No. 10, North Development North Road, Shenyang Economic and Technological Development Zone. The company currently consists of two parts: R&D center and production base.
The predecessor of the R&D center is a four-year-old personal laboratory and R&D team with a doctoral supervisor of Shenyang Pharmaceutical University and a postdoctoral returnee from Shenyang Pharmaceutical University. The research center currently has six laboratories including genetic engineering, enzyme engineering, fermentation engineering, pharmaceutical engineering (medicinal chemistry), separation and purification, and Chinese amplification functions, as well as a testing center and an information and intellectual property center. The backbone scientific research forces all come from large domestic and foreign pharmaceutical companies or well-known universities and enterprises. The University of Michigan, the University of Florida, the Brock University of Canada, the Shenyang Pharmaceutical University and Zhejiang University, etc., have maintained a long-term and close relationship with the company’s R&D center. Technical exchanges and cooperation. After hard work, the company currently has the innovative ability of genetic recombination biotechnology and strain construction, and has mature technology platforms such as genetic recombination, cell culture, and biological fermentation.
The production base covers an area of 62,000 square meters, with an annual output of 1,000 tons of pharmaceutical intermediates, with an annual output value of 1 billion. The main products include androstenedione (4-AD), androsta-1,4-diene-3,17-dione (ADD), 9а-hydroxyandrost-4-ene 3,17-dione (9а -OH-AD), progesterone, 9α-hydroxyprogesterone, 11β-hydroxyprogesterone, 17α-hydroxyprogesterone, 11-α,17-α-dihydroxyprogesterone, methyltestosterone, ursodeoxycholic acid, 10,13-Dimethyl-17-(1'-Hydroxyisopropyl)-12H-Cyclopentane [13,14]phenanthrene-4-en-3-one (PHM), 10,13-Dimethyl -17-(2'-Formylethyl)-12H-cyclopentane[13,14]phenanthrene-4-en-3-one, cortisone, hydrocortisone, prednisone, prednisolone , Dehydroepiandrosterone.